Lumida
/DMRA
⌘K
DMRA

DMRA

DMRA
$28.10USD+4.69%+1.26 today

MARKET CAP

1.7B

P/E (TTM)

FWD P/E

DAY RANGE

$27 – $29

52W RANGE

$17
$35

AI Summary

Stalk
TrimMedium

DMRA has decisively broken below key support zones and all short-term EMAs, confirming continuation of the downtrend in a Stage 4 distribution phase. The primary Support Failure pattern grants medium-term permission for bearish engagement, but the oversold context and a recent relief bounce suggest short-term relief rallies may occur. Execution should be deferred until rallies into the 9-day or 20-day EMA offer clear rejection opportunities. A sustained reclaim of broken support or a close above the EMAs with follow-through would invalidate the current bearish stance.

  • TD Cowen upgraded DMRA to strong-buy with a $44 price target
  • Analyst revision trends are positive, hinting at upward EPS expectations
  • Negative earnings yield and weak profitability hamper valuation
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %